Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Denator-led Research Project Aims to Develop New Biomarker Discovery Platform for Cancer Diagnostics

Published: Thursday, April 26, 2012
Last Updated: Thursday, April 26, 2012
Bookmark and Share
Project awarded funding from the EU Eurostars programme.

Denator AB has announced a joint research project, together with Erasmus Medical Center and Amsterdam Medical Center, which will be sponsored by the EU Eurostars program.

Aimed at developing a unique new biomarker discovery platform for cancer diagnostics, the project was ranked 3rd out of almost 300 European project applications.

The project will focus on the development and verification of a prototype platform to monitor specific protein/peptide degradation patterns in biological fluids and tissue sections using Denator’s proprietary heat-stabilization technology combined with an array of synthetic peptides.

Since degradation patterns are specific for different tissue types and also for specific diseases, this novel approach could enable the discovery of completely new disease markers to enable early cancer diagnosis.

Other partners in the consortium are based in The Netherlands at the Department of Neurology, Erasmus Medical Center, headed by Dr Theo Luider, and the Department of Gastroenterology, Amsterdam Medical Center, headed by Professor Jacques Bergman.

Dr. Theo Luider explained: “To utilize specific degradation patterns correlating to specific cancer types could provide the research community with an important tool to help advance the understanding of the complexity of cancer and eventual early diagnosis. This project holds the potential of immensely facilitating the diagnostic process.”

Olof Sköd, CEO of Denator, says: “This collaboration project will allow us to continue developing exciting new application areas for our heat stabilization technology. We are confident that working within such a strong team of innovative scientists presents a great opportunity for developing breakthrough diagnostic solutions.”

The Eurostars Programme is the European funding and support programme specifically dedicated to stimulating international collaborative research and innovation projects of small and medium enterprises.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Genetic Markers Influence Addiction
Differences in vulnerability to cocaine addiction and relapse linked to both inherited traits and epigenetics, U-M researchers find.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Fructose Alters Hundreds of Brain Genes
UCLA scientists report that diet rich in omega-3 fatty acids can reverse the damage.
DNA Barcodes Gone Wild
A team of researchers at University of Toronto’s Donnelly Centre and Sinai Health System’s Lunenfeld-Tanenbaum Research Institute (LTRI) has developed a new technology that can stitch together DNA barcodes inside a cell to simultaneously search amongst millions of protein pairs for protein interactions.
New Genetic Risk Factors for Myopia Discovered
Genes and environment determine short-sightedness.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!